Dextran Conjugation of Non–Steroidal Anti-Inflammatory Drug (Etodolac): A Colon Targeting Approach: Development of a Glucosamine-conjugated Etodolac Prodrug for Improved Targeting and Reduced Side Effects. (2019). Journal of Advances and Scholarly Researches in Allied Education, 16(6), 3589-3595. https://ignited.in/index.php/jasrae/article/view/11970